Benjamin K. Canales

Benjamin K. Canales

Auto-generated profile, based on publicly available information

Benjamin K. Canales

Department of Urology, University of Florida, Gainesville, Florida

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2021 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
PDF file
SKSaeed Khan
Saeed Khan
BCBenjamin K. Canales
Benjamin K. Canales
PDPaul R. Dominguez-Gutierrez
Paul R. Dominguez-Gutierrez

1 October 2010 in Urology
Verified
Journal Article
Closed access
BCBenjamin K. Canales
Benjamin K. Canales
LALorraine Anderson
Lorraine Anderson
LHLeeAnn Higgins
LeeAnn Higgins
KEKathy Ensrud-Bowlin
Kathy Ensrud-Bowlin
KRKen P. Roberts
Ken P. Roberts
MMManoj Monga
Manoj Monga


1 June 2008 in Journal of Endourology
Verified
Journal Article
Closed access
BCBenjamin K. Canales
Benjamin K. Canales
LALorraine Anderson
Lorraine Anderson
LHLeeann Higgins
Leeann Higgins
JSJoel Slaton
Joel Slaton
KRKen P. Roberts
Ken P. Roberts
MMManoj Monga
Manoj Monga
Background and Purpose: Previous efforts to identify the protein content of stone matrix have been limited by the lack of technology necessary to analyze the highly insoluble protein-crystalline complex. Our study objective is to characterize the matrix of calcium oxalate monohydrate (COM) stones using a comprehensive proteomics approach. Materials and Methods: Seven pure COM stones were powdered, and proteins were extracted using four different buffer solutions. Detergent cleanup spin columns or concentrators were used to remove detergent and to exchange buffers before trypsin digestion. Tryptic peptides were analyzed with reversed-phase, high-performance liquid chromatography (RP-HPLC) and tandem mass spectrometry (MS/MS) using a QSTAR Pulsar i quadrapole time of flight mass spectrometer. Tandem mass spectra were searched against National Center for Biotechnology Information human nonredundant database using ProteinPilot™ 1.0 software (Applied Biosystems, Inc.) for protein hits; peptide MS/MS spectra were manually inspected. Results: Of the four buffers, only 2% sodium dodecyl sulfate (SDS) samples had normal HPLC and MS/MS elution patterns. We identified 68 distinct proteins with >95% confidence. More than 50 of the proteins have not been previously identified in stone matrix. Of particular note, a significant number of inflammatory proteins were identified, including immunoglobulins, defensin α-3, clusterin, complement C3a, kininogen, and fibrinogen. Conclusions: SDS reducing buffer was efficient at solubilizing proteins from stone matrix for further MS-based proteomic analysis. A variety of cellular, structural, and plasma proteins comprise COM stone matrix. Several of the stone proteins are involved in cell injury pathways, which suggests that inflammation plays a role in human COM stone formation.

1 September 2013 in Journal of Urology
Verified
Journal Article
Closed access
BCBenjamin K. Canales
Benjamin K. Canales
JEJoseph Ellen
Joseph Ellen
SKSaeed R. Khan
Saeed R. Khan
MHMarguerite Hatch
Marguerite Hatch
We determined the effect of dietary fat and oxalate on fecal fat excretion and urine parameters in a rat model of Roux-en-Y gastric bypass surgery. Diet induced obese Sprague-Dawley® rats underwent sham surgery as controls (16), or Roux-en-Y gastric bypass surgery (19). After recovery, rats had free access to a normal calcium, high fat (40%) diet with or without 1.5% potassium oxalate for 5 weeks and then a normal (10%) fat diet for 2 weeks. Stool and urine were collected after each period. Fecal fat was determined by gas chromatography and urine metabolites were evaluated by assay spectrophotometry. Daily fecal fat excretion remained low in controls on either diet. However, Roux-en-Y gastric bypass rats ingested a food quantity similar to that of controls but had eightfold higher fecal fat excretion (p <0.001) and heavier stools (p = 0.02). Compared to controls, gastric bypass rats on the high fat diet with potassium oxalate had a fivefold increase in urine oxalate excretion (p <0.001), while gastric bypass rats without potassium oxalate had a twofold increase in urine calcium (p <0.01). Lowering dietary fat in gastric bypass rats with potassium oxalate led to a 50% decrease in oxalate excretion (p <0.01), a 30% decrease in urine calcium and a 0.3 U increase in urine pH (p <0.001). In this Roux-en-Y gastric bypass model high fat feeding resulted in steatorrhea, hyperoxaluria and low urine pH, which were partially reversible by lowering the dietary fat and oxalate content. Roux-en-Y gastric bypass rats on normal fat and no oxalate diets excreted twice as much oxalate as age matched, sham operated controls. Although Roux-en-Y gastric bypass hyperoxaluria appears primarily mediated by gut and diet, secondary causes of oxalogenesis from liver or other mechanisms deserve further exploration.

1 September 2009 in Journal of Endourology
Verified
Journal Article
Closed access
BCBenjamin K. Canales
Benjamin K. Canales
LHLeeAnn Higgins
LeeAnn Higgins
TMTodd Markowski
Todd Markowski
LALorraine Anderson
Lorraine Anderson
QLQin A. Li
Qin A. Li
MMManoj Monga
Manoj Monga
Purpose: Ureteral stents are susceptible to biofilm formation and crystal deposition, especially in stone formers. To identify proteins responsible for this accumulation, we compared conditioning film proteomes obtained from human ureteral stents with and without encrustation. Materials and Methods: Twenty-seven Bard Inlay™ hydrophilic ureteral stents were removed after ureteroscopy. Stent encrustation was quantified by visual analog score 0 (none) to 4 (heavy) and further categorized as nonencrusted (scores 0 and 1; n = 22) or encrusted (scores 2, 3, and 4; n = 5). Stent conditioning film was sampled and digested with trypsin, and peptide tandem mass spectrometry data were acquired using liquid chromatography. After protein identification, unconditional exact tests were used to compare categorical variables versus encrustation outcome. Stone analysis and follow-up metabolic urine profiles were examined to identify additional risk factors for stent encrustation. Results: More than 300 unique proteins with >95% confidence were identified. Proteins α-1 anti-trypsin, Ig kappa, IgH G1, and histone H2b and H3a were found to be highly associated with stent encrustation (p < 0.05), while Tamm-Horsfall protein and histone H2a were found to have a marginal association (p < 0.1). Patients with early stent encrustation were more likely to have mixed stone analysis (p = 0.03) and low urinary volumes (p < 0.01). Conclusion: Immunoglobulins and Tamm-Horsfall protein are common urinary proteins that appear to nonselectively bind early onto ureteral stent surfaces. Histones, nuclear DNA-condensing proteins, likely contribute to stent encrustation because of their unique net positive charge and may represent a potential clinical target for encrustation prevention.